Cic edizioni internazionali
Functional Neurology

Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey

Original Article, 253 - 258
doi: 10.11138/FNeur/2013.28.4.253
Tag this article
Abstract
Enhanced HTML Full text PDF
The aim of this survey was to provide an overview of important issues relating to therapeutic strategies based on botulinum toxin type A injection for the treatment of patients with neurological disorders.
Two hundred and ten physicians from neurology and neurorehabilitation units in Italian hospitals answered a questionnaire exploring some clinical aspects of the use of botulinum toxin type A in patients with spasticity/dystonia. 66% of the physicians treated patients with dystonia, 80% treated adults with spasticity, and 35% treated children with cerebral palsy.
Palpation with no instrumental guidance was the injection technique most commonly used for treating patients with dystonia, spasticity and cerebral palsy; 57% of the physicians evaluated patients instrumentally before toxin injection, while 45% assessed postinjection improvements by instrumental means; 78% of the physicians prescribed (when appropriate) rehabilitation procedures after toxin injection. Our results seem to show that the routine use of botulinum toxin in clinics is far from standardized.

Vol. XXXI (No. 4) 2016 October/December

  1. The challenge of in vivo tissue characterization, connectivity and big data
    Gandini Wheeler-Kingshott C.
    doi: 10.11138/FNeur/2016.31.4.189
  2. Network functional connectivity and whole-brain functional connectomics to investigate cognitive decline in neurodegenerative conditions
    Dipasquale O., Cercignani M.
    doi: 10.11138/FNeur/2016.31.4.191
  3. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias
    Del Sole A., Malaspina S., Magenta Biasina A.
    doi: 10.11138/FNeur/2016.31.4.205
  4. Modeling white matter microstructure
    Duval T., Stikov N., Cohen-Adad J.
    doi: 10.11138/FNeur/2016.31.4.217
  5. Reconstructing contralateral fiber tracts: methodological aspects of cerebello-thalamocortical pathway reconstruction
    Palesi F., Tournier J-D, Calamante F., Muhlert N., Castellazzi G., Chard D., D'Angelo E., Wheeler-Kingshott C.G.
    doi: 10.11138/FNeur/2016.31.4.229
  6. Impact of cerebellar atrophy on cortical gray matter and cerebellar peduncles as assessed by voxel-based morphometry and high angular resolution diffusion imaging
    Dayan M., Olivito G., Molinari M., Cercignani M., Bozzali M., Leggio M.
    doi: 10.11138/FNeur/2016.31.4.239
  7. Connectivity measures in the Poffenberger paradigm indicate hemispheric asymmetries
    Erbil N., Yagcioglu S.
    doi: 10.11138/FNeur/2016.31.4.249
  8. Main effects and interactions of cerebral hemispheres, gender, and age in the calculation of volumes and asymmetries of selected structures of episodic memory
    Ramirez-Carmona R., Garcia-Lazaro H.G., Dominguez-Corrales B., Aguilar-Castañeda E., Roldan-Valadez E.
    doi: 10.11138/FNeur/2016.31.4.257
Last Viewed articles: la lista degli ultimi x visitati.
  1. Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey
    Smania N., Colosimo C., Bentivoglio A.R., Sandrini G., Picelli A.
    doi: 10.11138/FNeur/2013.28.4.253
credits